共 171 条
[31]
Lange P(1997)Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma Qual Life Res 6 353-83
[32]
Parner J(1992)Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials Thorax 47 76-44
[33]
Vestbo J(1998)The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults Qual Life Res 7 235-43
[34]
Lange P(1997)Salmeterol and fluticasone propionate in the treatment of asthma symptoms Eur Resp Rev 7 338-16
[35]
Ulrik CS(1996)The use of inhaled ß2-adrenergic bronchodilators and anti-inflammatory steroids in asthma J Pharm Med 6 5-13
[36]
Vestbo J(1998)The complementary role of glucocorticosteroids and long-acting ß-adrenergic agonists Allergy 53 7-10
[37]
Reed CE(1999)Ligand-independent activation of the glucocorticoid receptor by β J Biol Chem 274 1005-9
[38]
Jacobson L(2000)-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells Respir Med 94 2-42
[39]
Hertzman P(1998)Improving patient compliance with asthma therapy Eur Resp Rev 8 239-9
[40]
Lofdahl CG(1999)Compliance in asthma Respir Med 93 763-62